About
Our Story
Our People
Careers
Science
Our Science
Pipeline
Izokibep
Lonigutamab
XLRN-517
Community
Patients
Partnerships
Investors
For Investors
Press Releases
Events
News Center
News Center
Media Kit
Contact

News Center

AllCompany NewsPress ReleasesEventsResources
An Interview With Our Chief Operating Officer Melanie Gloria
News
An Interview With Our Chief Operating Officer Melanie Gloria
Read more Arrow purple
An Interview With Our Chief Operating Officer Melanie Gloria
ACELYRIN, INC. Hosts KOL Panel Discussion at ACR Convergence 2022 on Role of Enthesitis in PsA and AxSpA
News
ACELYRIN, INC. Hosts KOL Panel Discussion at ACR Convergence 2022 on Role of Enthesitis in PsA and AxSpA
Read more Arrow purple
Courageous Caring in the Age of COVID
News
Courageous Caring in the Age of COVID
Read more Arrow purple
Dr. Shao-Lee Lin and Bob Carey talk strategy and more at ACELYRIN
News
Dr. Shao-Lee Lin and Bob Carey talk strategy and more at ACELYRIN
Read more Arrow purple

An innovative biopharma company that identifies, acquires and accelerates the development and commercialization of transformative medicines.

Get company updates to your inbox
About us
Our Story Our People Careers News Center
Science
Our Science Pipeline Izokibep Lonigutamab XLRN-517
Community
Investors Patients Partnerships
Contact
info@acelyrin.com Contact Us Media Kit
Gradient

©2023 ACELYRIN, INC. All Rights Reserved. | ACELYRIN and the ACELYRIN logo are trademarks of ACELYRIN, INC.

Acelyrin Linkedin
Privacy Policy | Terms